Submission to Health Canada - Agile Licensing for Drugs
Coûts des médicaments et des ordonnancesFixation du prix des médicaments
Tous les mémoires
The Canadian Life and Health Insurance Association (CLHIA) is pleased to provide the views of its members to Health Canada for consideration regarding the consultation on Agile Licensing for
Drugs, which proposes to make changes to drug review processes that reduce regulatory issues and roadblocks to innovation while making Canada’s regulatory system more agile and internationally aligned.
Drugs, which proposes to make changes to drug review processes that reduce regulatory issues and roadblocks to innovation while making Canada’s regulatory system more agile and internationally aligned.